Case report · 16 Aug 2025
Mini reviewPublished 21 Jun 2023
Heartbound Invaders: Reviewing Rare Malignant Carcinomas with Metastatic Fervor to the Heart
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Rare malignant carcinomas that metastasize to the heart present a complex and challenging clinical problem characterized by a poor prognosis. The spread of cancer cells to the heart, through the bloodstream or lymphatic system, can make treatment complicated, and the prognosis for these patients is generally challenging. Although rare, this type of cancer can occur in any type of cancer such as lung, breast, gastric, colorectal, pancreatic, and renal cell carcinomas. The difficulty in precise diagnosis is one of the factors contributing to the rareness of these tumors. The non-specificity of symptoms, including chest pain, shortness of breath, palpitations, and fatigue, often leads to misdiagnosis, mainly when presenting similarly to other heart diseases or cancer treatment side effects. Although the incidence of cardiac metastasis is relatively low compared to other types of cancer, it is increasing due to improved cancer diagnosis and treatment. Breast cancer elevates the risk of developing this type of cancer since it is among the most common types of tumors that metastasize to the heart. The treatment of cardiac metastasis is complicated and individualized as it relies on various factors such as cancer type, location, patient's overall health, and quality of life. Systemic chemotherapy, radiation therapy, and surgical resection are all potential therapeutic options. However, symptom relief takes precedence over curative modalities. The prognosis for cardiac metastasis is generally bleak since it is diagnosed at an advanced stage of the disease, and survival time can range from one to six months. Nevertheless, few case reports have shown prolonged survival rates, arising only after aggressive treatment. In conclusion, this complex and challenging clinical problem requires an accurate and precise diagnosis to prospectively determine and initiate the appropriate patient-specific treatment plan. Through the continued research and efforts of medical professionals, the prognosis of this specific type of cancer has the potential to improve, leading to better treatment options and standards of care for our patients.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Clinical Oncology: Case Reports.
Research article · 30 Jul 2025
A Peculiar Case of Chronic Myelomonocytic Leukemia with Myelodysplastic Syndrome Overlap Presenting with Acute Renal Failure
Case report · 30 Jul 2025
Vertebral Giant Cell Tumor in a Young Male with Early Aggressive Recurrence and Pulmonary Metastases: A Rare Case Report and Literature Review
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalClinical Oncology: Case Reports
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Carlos A. Cardenas”
- BylineArticles whose byline prints “Shabnam Abrishami”

